Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cassava Sciences Inc
(NQ:
SAVA
)
25.80
+0.94 (+3.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cassava Sciences Inc
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Navigating A Speculative Bubble
August 13, 2021
Invest while it inflates; protect before it pops.
Via
Talk Markets
Analyzing the Potential Risks of Cassava Sciences
August 13, 2021
Cassava Sciences has a promising drug candidate for Alzheimer's. However, SAVA stock may be overpriced based on the limited data so far.
Via
InvestorPlace
Why Is Cassava Sciences' Stock So Volatile?
August 12, 2021
The stock is up 1,700% year to date.
Via
The Motley Fool
Cassava Sciences vs. Biogen
August 12, 2021
Who will emerge victorious in the race to help Alzheimer's patients?
Via
The Motley Fool
Mid-Afternoon Market Update: Dow Drops 50 Points; IEC Electronics Shares Spike Higher
August 12, 2021
Toward the end of trading Thursday, the Dow traded down 0.14% to 35,435.25 while the NASDAQ rose 0.29% to 14,808.42. The S&P also rose, gaining 0.19% to 4,456.37. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Understanding Cassava Sciences's Unusual Options Activity
August 06, 2021
Cassava Sciences (NASDAQ:SAVA) shares experienced unusual ...
Via
Benzinga
Unusual Options Activity Insight: Cassava Sciences
August 03, 2021
Cassava Sciences (NASDAQ:SAVA) shares experienced unusual...
Via
Benzinga
Unusual Options Activity Insight: Cassava Sciences
July 30, 2021
On Friday, shares of Cassava Sciences (NASDAQ:SAVA) saw u...
Via
Benzinga
A Forgettable Week For Alzheimer's Treatment Stocks
July 30, 2021
Two of our top names that spiked last week come back down to earth. This is why we hedge.
Via
Talk Markets
Here's What Investors Should Know About Cassava's Alzheimer's Drug Candidate
August 11, 2021
Cassava believes that a mutating protein, Filamin A, is a major culprit behind Alzheimer's disease. The company's drug, simufilam, aims to fix this mutation and restore its proper form and function.
Via
The Motley Fool
Bring a Neck Brace When Trading Cassava Sciences
August 11, 2021
Cassava is still pre-revenue but SAVA stock has a flock of strong fans. They bought the dip with gumption, which suggests long-term success.
Via
InvestorPlace
Why Shares of Cassava Sciences Fell 18.6% in July
August 09, 2021
The stock lost $75 a share in two days at the end of the month.
Via
The Motley Fool
What to Do After Cassava Sciences Dropped Off a Cliff
August 09, 2021
Cassava Sciences posted positive clinical data but triggered a sell on the news event, as SAVA stock short sellers welcomed the drop.
Via
InvestorPlace
Cassava Sciences May Be Revolutionary in the Alzheimer’s Fight
August 05, 2021
SAVA stock is truly worth paying attention to from here forward as data suggests Cassava Sciences may have solved a big mystery.
Via
InvestorPlace
99 Biggest Movers From Yesterday
August 06, 2021
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...
Via
Benzinga
3 Things About Cassava Sciences That Smart Investors Know
August 05, 2021
Things are changing, but the picture is getting more positive as time goes on.
Via
The Motley Fool
75 Biggest Movers From Yesterday
August 04, 2021
Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that the it has received approval for a...
Via
Benzinga
Cassava Sciences Stock Has Been Hammered For No Good Reason and Is Likely To Rebound
August 03, 2021
Cassava Sciences stock has been hammered for no good reason. SAVA stock is still worth over $900 given the positive 9-mo results of Simufilam.
Via
InvestorPlace
48 Stocks Moving In Tuesday's Mid-Day Session
August 03, 2021
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 64.4% to $7.15 after a Form 4 filing from the company showed 10% shareholder Retail Ecommerce Ventures...
Via
Benzinga
Why Former NYSE Trader David Green Bought NVIDIA, Tesla, and Cassava Sciences On Tuesday
August 03, 2021
Veteran trader David Green was back live trading on Benzinga Tuesday morning, and the lon...
Via
Benzinga
61 Biggest Movers From Yesterday
August 03, 2021
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program....
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 02, 2021
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock increased by 35.01% to $5.5 during Monday's regular session. Trading volume for Xenetic Biosciences's stock is 10.1...
Via
Benzinga
A Forgettable Week For Alzheimer's Treatment Stocks: Two Of Our Top Names Come Back To Earth. This Is Why We Hedge.
August 02, 2021
Screen capture via Cassava Sciences' video for their Simufilam Alzheimer's disease treatment. Two Alzheimer's Names Come Back To Earth In a post last week (An...
Via
Benzinga
63 Biggest Movers From Friday
August 02, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
July 30, 2021
Gainers NanoVibronix (NASDAQ:NAOV) share...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 30, 2021
Gainers Erytech Pharma (NASDAQ:ERYP) sha...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 30, 2021
Gainers Erytech Pharma (NASDAQ:ERYP) shares moved upwards by 79.56% to $7.38 during Friday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Cassava Sciences Stock Has Plenty of Momentum After Positive Clinical Data
July 29, 2021
As Cassava Sciences made progress in treating Alzheimer's, SAVA stock is on a powerful path to significantly higher prices.
Via
InvestorPlace
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
July 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
70 Biggest Movers From Yesterday
July 30, 2021
Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently reported closing of $12.5 million private...
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.